TERMINATION AGREEMENT
Contract Categories:
Business Operations
- Termination Agreements
EX-10.2 5 v31294exv10w2.htm EXHIBIT 10.2 exv10w2
EXHIBIT 10.2
TERMINATION AGREEMENT
This TERMINATION AGREEMENT is entered into and effective as of June 22, 2007.
RECITALS:
WHEREAS, the parties hereto are parties to that certain Amended and Restated Recapitalization Agreement dated as of July 30, 2004 by and between the Company and Toucan Capital, as amended October 22, 2004, November 10, 2004, December 27, 2004, January 26, 2005, April 12, 2005, May 13, 2005, June 16, 2005, July 26, 2005, September 7, 2005 and November 14, 2005 (the Recapitalization Agreement).
WHEREAS, the parties to the Recapitalization Agreement now desire to terminate the Recapitalization Agreement, subject to the survival of certain provisions thereof.
AGREEMENTS:
NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:
1. Each of the Company and Toucan Capital hereby terminate the Recapitalization Agreement. Each party acknowledges that there shall be no further obligations under the Recapitalization Agreement following the date hereof other than (a) rights related to breaches of the Recapitalization Agreement occurring prior to the date hereof, and (b) the following provisions: (i) Section 4.4 (Indemnification), (ii) Section 4.5 (Injunctive Relief), and (iii) Section 4.13 (Miscellaneous).
2. This Termination may be executed in one or more counterparts, each of which shall be deemed an original but all of which taken together shall constitute one and the same instrument.
[Signature Page Follows]
IN WITNESS WHEREOF, each of the parties hereto has executed this Termination Agreement as of the date set forth above.
Northwest Biotherapeutics, Inc. | Toucan Capital Fund II, L.P. | |||||||||
By: | By: | |||||||||
Alton Boynton | Linda F. Powers | |||||||||
President | Managing Director | |||||||||
Address: | Address: | |||||||||
Northwest Biotherapeutics, Inc. | Linda F. Powers | |||||||||
Attention: Alton Boynton | Managing Director | |||||||||
18701 120th Avenue, NE, | Toucan Capital Corp. | |||||||||
Suite 101 | 7600 Wisconsin Ave, 7th Floor | |||||||||
Bothell, Washington 98011 | Bethesda, MD 20814 | |||||||||
Facsimile: 425 ###-###-#### | Facsimile: 240 ###-###-#### | |||||||||
E-Mail ***@*** | ||||||||||
Toucan Partners, LLC | ||||||||||
By: | ||||||||||
Linda F. Powers | ||||||||||
Managing Member | ||||||||||
Address: | ||||||||||
Toucan Partners, LLC | ||||||||||
7600 Wisconsin Avenue | ||||||||||
Suite 700 | ||||||||||
Bethesda, MD 20814 | ||||||||||
Facsimile: 240 ###-###-#### | ||||||||||
E-Mail ***@*** |